Clinical trials: Social Anxiety Disorder (Social Phobia)
Social Anxiety Disorder
PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2
This Phase 3 clinical trial is designed to evaluate the efficacy, safety, and tolerability of the acute administration of 3.2 µg of PH94B to relieve symptoms of anxiety in adult subjects with social anxiety disorder (SAD) during…
- Trial name
- Palisade-2 (NCT05011396)
- Testing
- PH94B Nasal Spray
- Where
- 15 sites in United States
- Volunteers
- 228 people
- Sponsor
- VistaGen Therapeutics, Inc.
Anxiety, Obsessive-Compulsive Disorder
Virtual Reality System for Anxiety and OCD
Cognitive Behavioral Therapy with fear provoking exposures is the most effective therapy for anxiety disorders. The investigators aim to enhance this therapy with the use of virtual reality exposures.
- Trial name
- NCT03636022
- Testing
- VR System, Control
- Where
- United States
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- Minnesota HealthSolutions
Social Phobia
Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder
This study is a Phase 2 trial to test the efficacy of LY686017 in the treatment of Social Anxiety Disorder.
- Trial name
- NCT00191022
- Testing
- LY686017, paroxetine
- Where
- 15 sites in United States
- Volunteers
- 185 people
- Sponsor
- Eli Lilly and Company
Panic Disorder, Generalized Anxiety Disorder
False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders
The aim of the current study was to test the efficacy of an individually administered, brief (5-session) transdiagnostic treatment for anxiety disorders.
- Conditions
- Panic Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder
- Trial name
- NCT02082561
- Testing
- Transdiagnostic Treatment (F-SET)
- Where
- United States
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- Florida State University
Social Anxiety Disorder
Self-Compassion Enhanced CBT vs. Standard CBT for Social Anxiety (SCE-CBT)
This study evaluates the addition of a self-compassion training in the treatment of social anxiety disorder. Half of the participants will receive a self-compassion enhanced group cognitive-behavioral therapy, while the other…
- Trial name
- SCE-CBT (NCT02646865)
- Testing
- Self-Compassion Enhanced Cognitive-Behavioral Therapy, Cognitive-Behavioral Therapy
- Where
- Romania
- Volunteers
- 60 people
- Sponsor
- Babes-Bolyai University
Social Anxiety Disorder, Generalized Anxiety Disorder
Visual Mismatch Negativity in Attention Bias Modifcation Treatment for Anxiety
this study examines the emergence of the visual mismatch negativity (vMMN) ERP component in response to deviations from the embedded contingency in attention bias modification treatment (ABMT) for social and generalized anxiety…
- Trial name
- NCT03016052
- Testing
- ABMT
- Where
- Israel
- Volunteers
- 80 people
- Sponsor
- Tel Aviv University
Social Anxiety, Social Anxiety Disorder
SOPHIE: Online-intervention for Prevention and Treatment of Social Anxiety in Adolescents
This study's aim is to investigate the efficacy of the online-intervention SOPHIE. SOPHIE is an online-intervention for adolescents with social anxiety.
- Trial name
- SOPHIE (NCT04782102)
- Testing
- SOPHIE Intervention
- Where
- Switzerland
- Volunteers
- 128 people
- Sponsor
- University of Bern
Social Anxiety Disorder, Social Anxiety
School-based Treatment of Social Anxiety With Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder
The goal of this randomized controlled trial is to find out whether the brief, 10-session Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder (DOCT-SAD) is more effective than standard counseling (SC) to treat…
- Conditions
- Social Anxiety Disorder, Social Anxiety, Adolescent - Emotional Problem
- Trial name
- SBT-DOCT-SAD (NCT06489639)
- Testing
- DOCT-SAD, SC
- Where
- Finland
- Volunteers
- 156 people
- Sponsor
- Klaus Ranta
Social Phobia, Anxiety
Virtual Reality Exposure Therapy for Speech Anxiety Using Commercial Hardware and Software
Virtual Reality Exposure Therapy (VRET) is an efficacious treatment of fear and anxiety, but because of the high financial costs and technical complexity of the past generation of VR hardware, there has been no large-scale…
- Conditions
- Social Phobia, Anxiety, Behavior Therapy
- Trial name
- VRETORIK (NCT03001154)
- Testing
- Face-to-face Virtual Reality Exposure Therapy, Internet-administered Virtual Reality Exposure Therapy, Waiting-list
- Where
- Sweden
- Volunteers
- 50 people
- Sponsor
- Stockholm University
Social Anxiety Disorder, Alcohol Use Disorders
Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting
The purpose of this study is to treat individuals with social anxiety disorder with a Food and Drug Administration-approved medication for the treatment of social anxiety disorder, the antidepressant paroxetine, and to evaluate…
- Trial name
- NCT00862212
- Testing
- Brief Alcohol Intervention
- Where
- 2 sites in United States
- Volunteers
- 83 people
- Sponsor
- Medical University of South Carolina
Social Anxiety Disorder
Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder
This study compares two treatment approaches for adolescents and young adults with social anxiety. One group will participate in therapy sessions using a virtual reality headset, while the other group will receive sertraline, a…
- Trial name
- NCT07192367
- Testing
- Virtual Reality Exposure Therapy, Sertraline (Oral Antidepressant)
- Where
- Turkey (Türkiye)
- Volunteers
- 56 people
- Sponsor
- Emine Kanmaz
Social Anxiety Disorder
Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder
This Phase 2 study (protocol number EMP-01-201) will determine the safety and tolerability of a short-term treatment with an oral dosage form of EMP-01 in adult participants with social anxiety disorder (SAD) and will assess…
- Trial name
- NCT06693609
- Testing
- EMP-01
- Where
- 7 sites in United Kingdom
- Volunteers
- 70 people
- Sponsor
- atai Therapeutics, Inc.
Social Anxiety Disorder
RESCCUE4 - Group CBT for Social Anxiety in Adolescents
This randomized controlled trial aims to evaluate the efficacy of a 2-month group Cognitive Behavioral Therapy (CBT) intervention compared to a structured psychoeducational treatment as usual (TAU) in adolescents diagnosed with…
- Trial name
- NCT07464561
- Testing
- Group Cognitive Behavioral Therapy, Psychoeducational Group Intervention
- Where
- Italy
- Volunteers
- 34 people
- Sponsor
- Bambino Gesù Hospital and Research Institute
Social Anxiety Disorder
Efficacy of Quetiapine in Generalised Social Anxiety Disorder
This trial will explore the efficacy of quetiapine in Social Anxiety Disorder, generalized type. The following elements of response will be tested: number of responders to treatment, time to response, effect size as measured with…
- Trial name
- NCT00302770
- Testing
- quetiapine
- Where
- Netherlands
- Volunteers
- 50 people
- Sponsor
- AstraZeneca
Social Anxiety Disorder
Statistical Learning as a Predictor of Attention Bias Modification Outcome
This study examines whether the ability to extract statistical properties from the environment among treatment-seeking patients with social anxiety disorder can predict therapeutic response to attention bias modification (ABM)…
- Trial name
- NCT03424967
- Testing
- ABM
- Where
- Israel
- Volunteers
- 30 people
- Sponsor
- Tel Aviv University
Phobic Disorders, Phobias
Glucocorticoid Treatment for Social Phobia
Social phobia is the third most common psychiatric disorder besides depression and alcoholism. Several studies have demonstrated the efficacy of cognitive-behavioral therapy in the treatment of social phobia.
- Trial name
- NCT01574014
- Testing
- CBGT, Hydrocortisone
- Where
- Switzerland
- Volunteers
- 66 people, healthy volunteers welcome
- Sponsor
- Insel Gruppe AG, University Hospital Bern
Social Anxiety Disorder
CvC-SAD (Clinician vs Coach)Self-help Versions in a RCT
Background: Social Anxiety Disorder (SAD) is a common mental problem, where people experience severe and disabling anxiety about social situations and interactions.
- Trial name
- NCT05292612
- Testing
- iCBT(C&W) for SAD
- Where
- Hong Kong
- Volunteers
- 110 people, healthy volunteers welcome
- Sponsor
- Chinese University of Hong Kong
Social Anxiety Disorder
Brief Intervention to Reduce Fear of Public Speaking
The study will test the efficacy of propranolol or placebo, administered after retrieval of a previously acquired public speaking fear, in reducing fear and avoidance of public speaking.
- Trial name
- NCT02790736
- Testing
- propranolol
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- New York State Psychiatric Institute
Panic Disorder, Agoraphobia
Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders
Anxiety disorders are the most common mental disorders in community settings, and they are associated with significant psychological distress, functional and social impairment.
- Conditions
- Panic Disorder, Agoraphobia, Social Anxiety Disorder, Generalized Anxiety Disorder
- Trial name
- T-CBT (NCT02811458)
- Testing
- Transdiagnostic Cognitive-Behavioral Therapy
- Where
- 3 sites in Canada
- Volunteers
- 231 people
- Sponsor
- Université de Sherbrooke
Social Anxiety Disorder, Performance Anxiety
Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder
The goal of the current proposal is to examine if sublingual riluzole can reduce anxiety in people with social anxiety disorder during a public speaking task.
- Trial name
- NCT03017508
- Testing
- BHV-0223
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- Yale University